Holen Sie sich die Stockscreener-App
241.89
0.23%
0.55
Handel nachbörslich:
241.89
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$241.34
Offen:
$240.79
24-Stunden-Volumen:
596.45K
Relative Volume:
0.78
Marktkapitalisierung:
$20.25B
Einnahmen:
$12.71B
Nettoeinkommen (Verlust:
$435.50M
KGV:
46.97
EPS:
5.15
Netto-Cashflow:
$843.20M
1W Leistung:
-1.78%
1M Leistung:
+9.83%
6M Leistung:
+0.93%
1J Leistung:
+20.23%
1-Tages-Spanne:
$239.83
$243.30
1-Wochen-Bereich:
$239.83
$251.67
52-Wochen-Spanne:
$191.97
$258.59
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Vergleichen Sie LH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
241.89 | 20.61B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
400.48 | 152.86B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
187.48 | 136.66B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
504.83 | 41.18B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
109.68 | 32.05B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
138.04 | 24.29B | 15.50B | 1.33B | 2.16B | 7.34 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Chart of the Day: LabCorp Isn't Passing the Growth Test Yet - TheStreet Pro
Mizuho lifts LabCorp stock target to $274, keeps Outperform rating By Investing.com - Investing.com Nigeria
Labcorp Holdings (NYSE:LH) Partners With Frame to Enhance Fertility Testing Access - Yahoo Finance
Mizuho lifts LabCorp stock target to $274, keeps Outperform rating - Investing.com
Mizuho Adjusts Price Target on Labcorp Holdings to $274 From $264, Maintains Outperform Rating - marketscreener.com
Labcorp Holdings Inc. (LH) Announces Approval of 2025 Incentive and Stock Purchase Plans - GuruFocus
Labcorp shareholders approve new incentive plans By Investing.com - Investing.com Nigeria
Labcorp shareholders approve new incentive plans - Investing.com
Labcorp Holdings Approves Key Proposals at Annual Meeting - TipRanks
Here's Why Labcorp (LH) is a Strong Value Stock - Yahoo Finance
Baird Adjusts Price Target on Labcorp Holdings to $268 From $267, Maintains Outperform Rating - marketscreener.com
Here's Why Labcorp (LH) is a Strong Momentum Stock - Yahoo Finance
Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - GlobeNewswire Inc.
Zacks Industry Outlook Highlights Cardinal Health, Labcorp And Align Technology - Barchart.com
Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology - Yahoo Finance
Labcorp Holdings CEO Adam Schechter sells $1.52 million in stock By Investing.com - Investing.com South Africa
Labcorp Holdings CEO Adam Schechter sells $1.52 million in stock - Investing.com Australia
Insider Sell: Adam Schechter Sells Shares of Labcorp Holdings In - GuruFocus
Insider Sell: Adam Schechter Sells Shares of Labcorp Holdings Inc (LH) - GuruFocus
Labcorp Holdings Insider Sold Shares Worth $1,518,497, According to a Recent SEC Filing - marketscreener.com
LH Q1 Earnings Call: Labcorp Grows Revenue but Misses Expectations, Raises Adjusted EPS Guidance - Yahoo Finance
Labcorp Holdings (LH) Price Target Raised by Truist Securities | - GuruFocus
Labcorp (LH) Price Target Raised by Truist Analyst to $290 | LH Stock News - GuruFocus
Labcorp to Webcast Its Annual Meeting of Shareholders May 15 - The Malaysian Reserve
LabCorp Holdings Inc. (LH) Files Form 8-K with SEC - GuruFocus
Labcorp Holdings to Webcast Annual Shareholder Meeting - TipRanks
Justices' Labcorp Questions Explore Class Cert. Tensions - Law360
Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72 - Yahoo Finance
Most Shareholders Will Probably Agree With Labcorp Holdings Inc.'s (NYSE:LH) CEO Compensation - simplywall.st
Labcorp Holdings' (NYSE:LH) Earnings May Just Be The Starting Point - Yahoo Finance
How A Labcorp Ruling Could Affect Wage Class Actions - Law360
Labcorp Holdings (LH) Price Target Raised by Piper Sandler | LH Stock News - GuruFocus
Analyst Expectations For Labcorp Hldgs's Future - Benzinga
Piper Sandler Adjusts Labcorp Holdings Price Target to $280 From $260, Maintains Neutral Rating - marketscreener.com
Labcorp case at Supreme Court could set precedent for class-action lawsuits - The Business Journals
Labcorp (LH) Receives Price Target Boost from Piper Sandler | LH Stock News - GuruFocus
Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight - GuruFocus
Labcorp Holdings Inc, BioReference Health, OPKO Health, Inc. - Olean Times Herald
Labcorp: Q1 Earnings Snapshot - Bluefield Daily Telegraph
Why Labcorp (LH) is a Top Value Stock for the Long-Term - Yahoo Finance
BlackRock, Inc. Reduces Stake in Labcorp Holdings Inc. - GuruFocus
Labcorp Outpaces Expectations With Strong Diagnostic Demand - Finimize
Baird Adjusts Labcorp Holdings' Price Target to $267 From $253 - marketscreener.com
Labcorp (LH) Price Target Raised by Baird Following Q1 Results | - GuruFocus
Labcorp’s Stock Price Target Raised on Strong Q1 (NYSE: LH) - AskTraders.com
Labcorp Holdings First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Barclays Adjusts Labcorp (LH) Price Target, Maintains Equal Weig - GuruFocus
Barclays Adjusts Labcorp (LH) Price Target, Maintains Equal Weight Rating | LH Stock News - GuruFocus
Labcorp targets 10% EPS growth with new diagnostics and acquisitions strategy - MSN
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):